Strides Pharma Science Ltd
NSE:STAR

Watchlist Manager
Strides Pharma Science Ltd Logo
Strides Pharma Science Ltd
NSE:STAR
Watchlist
Price: 920.2 INR 2.16%
Market Cap: 84.8B INR

Strides Pharma Science Ltd
Operating Expenses

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Strides Pharma Science Ltd
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Strides Pharma Science Ltd
NSE:STAR
Operating Expenses
-₹20.6B
CAGR 3-Years
-3%
CAGR 5-Years
-8%
CAGR 10-Years
-14%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Operating Expenses
-₹162.2B
CAGR 3-Years
-14%
CAGR 5-Years
-12%
CAGR 10-Years
-14%
Cipla Ltd
NSE:CIPLA
Operating Expenses
-₹131.7B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-8%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Operating Expenses
-₹307.3B
CAGR 3-Years
-12%
CAGR 5-Years
-11%
CAGR 10-Years
-8%
Lupin Ltd
NSE:LUPIN
Operating Expenses
-₹125.9B
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
-8%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Operating Expenses
-₹60.8B
CAGR 3-Years
-11%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
No Stocks Found

Strides Pharma Science Ltd
Glance View

Strides Pharma Science Ltd. engages in the development, manufacture and distribution of Internet Protocol-led generics and bio-pharmaceutical products. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2000-02-03. The firm is focused on development and manufacture of IP-led niche and pharmaceutical products. The company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The firm manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as, liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. The company has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). The company is also engaged in manufacturing soft gelatin capsules. The company develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.

STAR Intrinsic Value
1 271.17 INR
Undervaluation 28%
Intrinsic Value
Price

See Also

What is Strides Pharma Science Ltd's Operating Expenses?
Operating Expenses
-20.6B INR

Based on the financial report for Sep 30, 2025, Strides Pharma Science Ltd's Operating Expenses amounts to -20.6B INR.

What is Strides Pharma Science Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-14%

Over the last year, the Operating Expenses growth was -4%. The average annual Operating Expenses growth rates for Strides Pharma Science Ltd have been -3% over the past three years , -8% over the past five years , and -14% over the past ten years .

Back to Top